Mehmedovic Aldin, Konstantinou Nikolaos, Jerkku Thomas, Pichlmaier Maximilian, Kölbel Tilo, Rantner Barbara, Banafsche Ramin, Tsilimparis Nikolaos
Abteilung für Gefäßchirurgie - Vaskuläre und Endovaskuläre Chirurgie, Klinikum der Universität München, Campus Großhadern, München, Deutschland.
Herzchirurgische Klinik und Poliklinik, Klinikum der Universität München, Campus Großhadern, München, Deutschland.
Zentralbl Chir. 2020 Oct;145(5):432-437. doi: 10.1055/a-1186-2554. Epub 2020 Jul 13.
Five years after the first endovascular aortic repair (EVAR), Park et al. reported the first implantation of a fenestrated endoprosthesis. In the meantime, advanced generations of new fenestrated and branched endografts evolved. Endografts for complex pathologies are either so-called "off-the-shelf" grafts with predetermined length, width, diameter and clock position of the branches and fenestrations, predetermined by the manufacturer, "custom-made" grafts which need to be sized and planned individually for patients with specific thoracoabdominal anatomy. Open aortic repair in the treatment of thoracoabdominal aortic aneurysm (TAAA) still remains challenging and is associated with high morbidity and mortality, even in the elective setting. The ongoing development of endovascular treatment modalities, such as fenestrated and branched endovascular aneurysm repair (F-EVAR, B-EVAR), enables less invasive procedures for more challenging aortic pathologies. In recent years, extensive endovascular treatment of the aortic arch to the thoracoabdominal segment has become more and more important, but its outcomes have not been completely evaluated. The aim of this is article is to provide an overview of the currently available endovascular treatment options for complex aortic aneurysms requiring extensive coverage from the aortic arch to the infrarenal aorta.
在首次进行血管腔内主动脉修复术(EVAR)五年后,朴等人报道了首例开窗型腔内血管修复装置的植入。与此同时,新一代先进的开窗型和分支型腔内血管修复装置不断涌现。用于复杂病变的腔内血管修复装置,要么是制造商预先确定了分支和开窗的长度、宽度、直径及时钟位置的所谓“现货”移植物,要么是需要针对具有特定胸腹解剖结构的患者进行个体化尺寸测量和规划的“定制”移植物。即使在择期手术中,开放主动脉修复术治疗胸腹主动脉瘤(TAAA)仍然具有挑战性,且与高发病率和死亡率相关。血管腔内治疗方式的不断发展,如开窗型和分支型血管腔内动脉瘤修复术(F-EVAR,B-EVAR),使得对更具挑战性的主动脉病变能够采用侵入性较小的手术。近年来,从主动脉弓到胸腹段的广泛血管腔内治疗变得越来越重要,但其效果尚未得到全面评估。本文的目的是概述当前可用于需要从主动脉弓到肾下主动脉广泛覆盖的复杂主动脉瘤的血管腔内治疗选择。